Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

Late Clinical Development of KH176: an innovative orphan drug to reach mitochondrial disease patients & market

Dal 2018-10-01 al 2020-09-30, progetto in corso

Dettagli del progetto

Costo totale:

EUR 3 337 525

Contributo UE:

EUR 2 336 267,50

Coordinato in:

Netherlands

Invito a presentare proposte:

H2020-SMEInst-2018-2020-2See other projects for this call

Meccanismo di finanziamento:

SME-2 - SME instrument phase 2

Obiettivo

Coordinatore

KHONDRION BV
Netherlands

Contributo UE: EUR 2 336 267,50


VAN HEEMSTRAWEG 49 E
6641 AA BEUNINGEN
Netherlands
See on map
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation